case_images: PMC5070250_01
case_images: Bone marrow examination showing the diagnosis of pure red cell aplasia after imatinib initiation.
case_images: esmoopen2016000058f01.jpg
case_images: PMC5070250_01_esmoopen2016000058f01.jpg
case_images: ESMOOPEN2016000058F1
case_images: A repeat bone marrow examination showed PRCA (figure 1).
case_images: Bone marrow examination showing the diagnosis of PRCA after nilotinib initiation.
case_images: esmoopen2016000058f02.jpg
case_images: PMC5070250_01_esmoopen2016000058f02.jpg
case_images: ESMOOPEN2016000058F2
case_images: The repeat bone marrow examination again showed PRCA (figure 2).
case_images: Changes in haemoglobin over the course of the treatment in a patient with chronic myeloid leukaemia who developed pure red cell aplasia secondary to imatinib and nilotinib. The effect of each intervention in the haemoglobin count is depicted. Hb, haemoglobin.
case_images: esmoopen2016000058f03.jpg
case_images: PMC5070250_01_esmoopen2016000058f03.jpg
case_images: ESMOOPEN2016000058F3
case_images: The changes in Hb count parallel to the interventions are depicted graphically in figure 3.